Registro:

Referencias:

• Holm, B., Bosstad, F., Kierulf, P., Godal, H., Polimerization properties of two normally circulating, HMW and LMW. Evidence that the COOH-terminal end of the α-chain is of importance for fibrin polimerization (1985) Thromb. Res., 39, pp. 595-606
• Fu, Y., Weissbach, L., Plant, P., Oddux, C., Cao, Y., Liang, T., Roy, S., Grieninger, G., Carboxi-terminal-extended variant of the human fibrinogen a subunit: A novel exon marked homology to β and γ subunits (1992) Biochemistry, 31, pp. 11968-11972
• Blomback, B., Fibrinogen structure, activation, polymerization and fibrin gel structure (1994) Thromb. Res., 75 (3), pp. 327-328
• Townsend, R., Hilliker, E., Li, Y., Carbohydrate structure of human fibrinogen (1982) J. Biol. Chem., 257, pp. 9704-9708
• Fowler, W., Erickson, H., Trinodular structure of fibrinogen. Confirmation by both shadowing and negative stain electron microscopy (1979) J. Mol. Biol., 134, pp. 241-246
• Doolittle, R., Fibrinogen and fibrin (1994) Sci. Am., 245, pp. 92-101
• Hermans, J., Mcdonagh, J., Fibrin: Structure and interactions (1982) Sem. Thromb. Hemost., 8, pp. 11-24
• Pisano, J., Finlayson, J., Peyton, M., Cross-link fibrin polymerized by factor XIII (γ-glutamyl) lysine (1968) Science, 160, pp. 892-895
• Di Minno, G., Mancini, M., Measuring plasma fibrinogen to predict stroke and miocardial infarction (1990) Atherosclerosis, 10, pp. 1-7
• Barnhart, M., Cress, D., Noonan, S., Walsh, R., Influence of fibrinolytic products on hepatic release and synthesis of fibrinogen (1970) Thromb. Haemost. Suppl., 39, pp. 143-159
• Louache, F., Fibrinogen is not synthetisez by human megakaryocytes (1991) Blood, 77 (2), pp. 311-316
• Lange, W., Luig, A., Fibrinogen gamma-chain mRNA is not detected in human megakaryocytes (1991) Blood, 78 (1), pp. 20-25
• Cratree, G., Comeau, C., Fowlkes, D., Nace, A., Malley, J., Kant, J., Evolution and structure of the fibrinogen genes. Random insertion of introns or selective loss? (1985) J. Biol. Chem., 185, pp. 1-19
• Yu, S., Sher, B., Kudryk, B., Redman, C., Intracellular assembly of human fibrinogen? (1983) J. Biol. Chem., 258, pp. 13407-13410
• Collen, D., Tytgat, G., Claeys, H., Piessens, R., Metabolism and distribution of fibrinogen (1972) Br. J. Haematol., 22, pp. 681-699
• Martinez, J., Holburn, R., Shapiro, S., Erslev, A., Fibrinogen Philadelphia (1974) J. Clin. Investig., 53, pp. 600-611
• Morell, A., Gregoriadis, G., Scheinberg, I., The role of sialic acid in determing the survival of glycoproteins in the circulation (1971) J. Biol. Chem., 246, pp. 1461-1465
• Mcfarlane, A., Todd, D., Cromwell, S., Fibrinogen catabolism humans (1964) Clin. Sci., 26, pp. 415-420
• Roy, S., Yu, S., Banerjee, D., Overtom, O., Assembly and secretion of fibrinogen. Degradation of individual chains (1992) J. Biol. Chem., 267 (32), pp. 23151-23158
• Hamsten, A., Iselius, L., De Faire, U., Blomback, M., Genetic and cultural inheritance of plasma fibrinogen concentration (1987) Lancet, 2, pp. 988-990
• Margaglione, M., Di Minno, G., Grandone, E., Raised plasma fibrinogen concentrations in subjets attending a metabolic ward. Relation to family history and vascular risk factors (1995) Thromb. Haemostas., 73, pp. 579-583
• Heinrich, J., Funke, H., Rust, S., Impact of polymorphins in the alpha- And betha-fibrinogen gene on plasma fibrinogen concentrations of coronary disease patients (1995) Thromb. Res., 77, pp. 209-215
• Unwin, N., Harland, J., Fisher, W., The epidemiology of fibrinogen in a UK Chinese population (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), p. 6. , Abst. 0-14
• Iso, H., Folsom, A., Winkelmann, J., Polymorphins of the beta fibrinogen gen and plasma fibrinogen concentration in Caucasian and Japanese population samples (1995) Thromb. Haemostas., 73, pp. 106-111
• Folsom, A., Wu, K., Epidemiology of plasma fibrinogen (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), p. 7. , Abst. 0-16
• Iso, H., Folsom, A., Sato, S., Wu, K., Shimamoto, T., Koike, K., Iida, M., Komachi, I., Plasma fibrinogen and its correlates in Japanese and US population samples (1993) Arterioscler. Thromb., 13, pp. 783-790
• Van Der Bom, J., Bots, M., Grobbee, D., Seasonal variations of plasma fibrinogen and leukocytes are dissociated in the Rotterdam Study (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), pp. 8-9
• Stout, R., Crawford, V., Seasonal variations in fibrinogen concentrations among elderly people (1991) Lancet, 338, pp. 9-13
• Eliasson, M., Ervin, P., Lundblad, D., Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen. A population study (1993) Fibrinolysis, 7, pp. 316-323
• Balleisen, L., Bailey, J., Epping, P., Epidemiological study on factor VII and fibrinogen in an industrial population: Baseline data on relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause (1985) Thromb. Haemostas., 54, pp. 475-479
• Maseri, A., Biasucci, L., Andreotti, F., Age dependence of ischaemic heart syndromes and the contribution of haemostatic deviations (1992) Fibrinolysis, 6 (3 SUPPL.), pp. 3-4
• Haverkate, F., Thomson, S., Duckest, F., Haemostasis factors in angina pectoris: Relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group (1995) Thromb. Haemostas., 73, pp. 561-567
• Rosengrem, A., Wilhelmsen, L., Fibrinogen and coronary heart disease in smokers and no smokers. the study of men born in 1933 (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), p. 10. , Abst. 0-23
• Jern, C., Eriksson, E., Tengborn, L., Changes of plasma coagulation and fibrinolysis in response to mental stress (1989) Thromb. Haemostas., 62, pp. 767-771
• Lee, A., Flanagan, P., Rumley, F., Relationship between alcohol intake and tissue plasminogen activator antigen and other haemostatic factors in the general population (1995) Fibrinolysis, 9, pp. 49-54
• Oousthizen, W., Vorster, H., Herling, L., Both fish oil and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels (1994) Thromb. Haemostas., 72 (4), pp. 557-562
• Elwood, P., Yarnell, J., Pickering, J., Fehily, A., O'Brien, J., Exercise, fibrinogen and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study (1993) Br. Heart J., 69 (2), pp. 183-187
• Pechetl, A., Alexander, B., Increased clotting factors in pregnancy (1961) N. Engl. J. Med., 265, pp. 1093-1095
• Scarabin, P., Plu-Bureau, G., Bara, L., Haemostatic variables and menopausal status: Influence of hormonr replacement therapy (1993) Thromb. Haemost., 70, pp. 584-587
• Downtown, S., Goten, H., Acute phase reactants in inflamation and infection (1988) Sem. Hematol., 25, pp. 84-90
• Amrani, D., Regulation of fibrinogen biosyntesis: Glucocorticoid and interleikin-6 con- Trol (1990) Blood Coag. Fibrin., 1, pp. 443-446
• Lechner, K., Niesser, H., Thaler, E., Coagulation abnormalities in liver disease (1977) Semi. Thromb. Hemos., 40, pp. 40-45
• Berglund, U., Wallentin, L., Von Schenck, H., Platelet function and plasma fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of myocardial infarction (1988) Thromb. Haemostas., 60, pp. 21-24
• Mazoyer, E., Ripoll, L., Boisseau, M., Drouet, L., How does ticlopidine lower plasma fibrinogen (1994) Thromb. Res., 75 (3), pp. 361-370
• Gralnick, H., Henderson, E., Hypofibrinogenemia and coagulation factor deficiencies with 1-asparaginase treatment (1971) Cancer, 27, pp. 1.313-1.316
• Meade, T., Imeson, Stirling, Y., Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease (1987) Lancet, 2, pp. 986-988
• Wilhelmsen, L., Svarsudd, K., Korsan Bengtsen, K., Larson, B., Wellin, L., Tibblin, G., Fibrinogen as a risk factor for stroke and myocardial infarction (1984) N. Engl. J. Med., 311, pp. 501-505
• Ridker, P., Hennekens, C., Hemostatic risk factor for coronary heart disease (1991) Circulation, 83, pp. 1.098-1.100
• Qizilbash, N., Fibrinogen and cerebrovascular disease: An overview (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), p. 14. , Abst. 0-31
• Meade, T., Chakarabarti, R., Haemostatic function and cardiovascular death: Early results of a prospective study (1980) Lancet, 2, pp. 1.050-1.053
• Meade, T., Brozovic, M., Chakrabarti, R., Haemostatic function and ischaemic heart disease: Principal results of Northwick Park Heart Study (1986) Lancet, 2, pp. 533-533
• Wihelmsen, L., Svarsudd, K., Korsan-Bentsen, K., Fibrinogen as a risk factor for stroke and myocardial infarction (1984) N. Eng. J. Med., 311, pp. 501-505
• Kannel, W., Wolf, P., Castelli, W., D'Agostino, R., Fibrinogen and risk of cardiovascular disease", the Framingham Study (1987) JAMA, 258, pp. 1.183-1.186
• Heinrich, J., Schulte, H., Balleisen, L., Predictive value of haemostatic variables in the PROCAM study (1991) Thromb. Haemostas., 65, p. 815. , Abst. 466
• Fowkes, F., Fibrinogen and peripheral arterial disease (1995) Eur. Heart J., 16 (SUPPL. A), pp. 36-40
• Meade, T., Fibrinogen is ischaemic heart disease (1995) Eur. Heart. J., 16 (SUPPL. A), pp. 31-34
• Eber, B., Schumacher, M., Fibrinogen: Its role in the hemostatic regulation in atherosclerosis (1993) Sem. Thromb. Hemos., 19 (2), pp. 104-107
• Yarnell, Y., Mccrum, E., Evans, A., Determinants of plasma fibrinogen and viscosity: Gender differences in the Belfast MONICA Surveys and in the other MONICA populations (1994) Blood Clog. Fibrin., 5 (2 SUPPL.), pp. 6-7
• Yarnell, Y., Baker, I., Sweetnam, P., Fibrinogen, viscosity and white blood cell count are major riskfactors for ischemic heart disease. the Caerphilly and Speedwell Collaborative Heart Disease Studies (1991) Circulation, 83, pp. 836-844
• Blomback, B., Okada, M., Fibrin gel structure and clotting time (1982) Thromb. Res., 25, pp. 51-70
• Blomback, B., Carlsson, K., Fatah, K., Hessel, B., Procyk, R., Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation (1994) Thromb. Res., 75, pp. 521-538
• Fatah, K., Hamsten, A., Blomback, B., Blomback, M., Fibrin gel network characteristics and coronary heart disease: Relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis (1992) Thromb. Haemostas., 68, pp. 130-135
• Mcdonagh, J., Suppressin of plasminogen binding to fibrin by high fibrinogen: A mechanism for how fibrinogen enhances the risk of thrombosis (1994) Thrombosis, 4, pp. I-XX
• Vasse, M., Collet, J., Soria, J., Mirshashi, S., Vannier, J., Soria, C., Fibrinogen, a vascular risk factor: A simple marker or a real cause of vascular lesion (1994) Thromb. Res., 75 (3), pp. 349-352
• Smith, E., Thompson, W., Fibrin as a factor in atherogenesis (1994) Thromb Res., 73, pp. 1-19
• Vasse, M., Mirshahi, S., Soria, J., Mirshahi, M., Borg, J., Monconduit, M., Soria, C., Potent activity of peripheral blood lymphocytes in inducing hepaticyte stimulating factor and urokinase in monocytes (1993) Blood Coag. and Fibrin., 4, pp. 143-147

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------